Data / Form D filings / Zena Therapeutics Inc.
Zena Therapeutics Inc.: Form D filing
Zena Therapeutics Inc., a pharmaceuticals company in Princeton, NJ, filed a Form D with the SEC in 2023. The latest, on September 7, 2023, reports $500,000 sold of a $500,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 155 VILLAGE BLVD, SUITE 130, Princeton, NJ, 08540
- Phone
- (848) 229-4215
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1992540
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 7, 2023 | New notice | $500,000 | $500,000 | 1 | Aug 11, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eileen Carry | Executive Officer, Director | |
| Ariane Vasilatis | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Sep 4, 2023 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Zena Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.